Literature DB >> 1469402

Fluctuating cognitive abnormalities and cerebral glucose metabolism in neuropsychiatric systemic lupus erythematosus.

R M Carbotte1, S D Denburg, J A Denburg, C Nahmias, E S Garnett.   

Abstract

Brain imaging techniques such as MRI and PET have the potential for identifying central nervous system involvement in SLE. They may also help elucidate the mechanisms giving rise to the widely diverging manifestations of CNS involvement in SLE. This report documents an intensive longitudinal study of three women with neuropsychiatric SLE. PET and neuropsychological evaluation were both used to examine the co-occurrence of behavioural/cognitive deficits with alterations in regional brain glucose metabolism. In all three patients, FDG uptake indicated abnormalities which were not identified on CT scan, but corresponded well with localisable cognitive deficits. Changes in each patient's cognitive profile on reassessment paralleled changes on PET. These findings support the suggestion that cognitive deficits in SLE patients reflect primary CNS involvement.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1469402      PMCID： PMC1015292          DOI： 10.1136/jnnp.55.11.1054

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  26 in total

1.  Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning.

Authors:  W J McCune; A MacGuire; A Aisen; S Gebarski
Journal:  Arthritis Rheum       Date:  1988-02

2.  Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus.

Authors:  W L Sibbitt; R R Sibbitt; R H Griffey; C Eckel; A D Bankhurst
Journal:  Ann Rheum Dis       Date:  1989-12       Impact factor: 19.103

3.  Positron emission tomography in neuropsychiatric lupus erythematosus.

Authors:  G Stoppe; K Wildhagen; J W Seidel; G J Meyer; O Schober; P Heintz; H Künkel; H Deicher; H Hundeshagen
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

4.  Cerebral involvement in systemic lupus erythematosus.

Authors:  N D Volkow; N Warner; R McIntyre; A Valentine; M Kulkarni; N Mullani; L Gould
Journal:  Am J Physiol Imaging       Date:  1988

5.  Cerebral blood flow in systemic lupus erythematosus with or without cerebral complications.

Authors:  M J Kushner; J Chawluk; F Fazekas; B Mandell; A Burke; J Jaggi; M Rosen; M Reivich
Journal:  Neurology       Date:  1987-10       Impact factor: 9.910

6.  Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement.

Authors:  H H Awada; H L Mamo; A G Luft; J C Ponsin; M F Kahn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-12       Impact factor: 10.154

7.  Prevalence of cognitive impairment in systemic lupus erythematosus.

Authors:  R M Carbotte; S D Denburg; J A Denburg
Journal:  J Nerv Ment Dis       Date:  1986-06       Impact factor: 2.254

8.  Oxygen-15 brain scanning for detection of cerebral involvement in systemic lupus erythematosus.

Authors:  A J Pinching; R L Travers; G R Hughes; T Jones; S Moss
Journal:  Lancet       Date:  1978-04-29       Impact factor: 79.321

9.  Response of human-immunodeficiency-virus-associated neurological disease to 3'-azido-3'-deoxythymidine.

Authors:  R Yarchoan; G Berg; P Brouwers; M A Fischl; A R Spitzer; A Wichman; J Grafman; R V Thomas; B Safai; A Brunetti
Journal:  Lancet       Date:  1987-01-17       Impact factor: 79.321

10.  Magnetic resonance imaging and computerized tomography in relation to the neurobehavioral sequelae of mild and moderate head injuries.

Authors:  H S Levin; E Amparo; H M Eisenberg; D H Williams; W M High; C B McArdle; R L Weiner
Journal:  J Neurosurg       Date:  1987-05       Impact factor: 5.115
View more
  11 in total

Review 1.  Cognitive dysfunction in the patient with antiphospholipid antibodies: considerations for cause and treatment.

Authors:  Melanie J Harrison; Lisa D Ravdin
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

Review 2.  Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE).

Authors:  R A Asherson; S D Denburg; J A Denburg; R M Carbotte; N Futrell
Journal:  Postgrad Med J       Date:  1993-08       Impact factor: 2.401

3.  Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET.

Authors:  S M Weiner; A Otte; M Schumacher; R Klein; J Gutfleisch; I Brink; P Otto; E U Nitzsche; E Moser; H H Peter
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

4.  Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT.

Authors:  S S Sun; W S Huang; J J H Chen; C P Chang; C H Kao; J J Wang
Journal:  Eur Radiol       Date:  2003-12-09       Impact factor: 5.315

5.  Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.

Authors:  P Colamussi; M Giganti; C Cittanti; L Dovigo; F Trotta; M R Tola; R Tamarozzi; G Lucignani; A Piffanelli
Journal:  Eur J Nucl Med       Date:  1995-01

6.  Usefulness of Tc-99m ECD brain SPECT to evaluate the effects of methylprednisolone pulse therapy in lupus erythematosus with brain involvement: a preliminary report.

Authors:  F Y Liu; W S Huang; C H Kao; R F Yen; J J Wang; S T Ho
Journal:  Rheumatol Int       Date:  2003-01-30       Impact factor: 2.631

7.  Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms.

Authors:  K Kodama; S Okada; T Hino; K Takabayashi; Y Nawata; Y Uchida; N Yamanouchi; N Komatsu; T Ikeda; N Shinoda
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

8.  18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.

Authors:  F Grünwald; A Schomburg; A Badali; J Ruhlmann; L Pavics; H J Biersack
Journal:  Eur J Nucl Med       Date:  1995-09

9.  Posterior reversible encephalopathy syndrome could be an underestimated variant of "reversible neurological deficits" in Systemic Lupus Erythematosus.

Authors:  Bin Liu; Xuan Zhang; Feng-Chun Zhang; Yuan Yao; Ri-Zhi Zhou; Miao-Miao Xin; Li-Qin Wang
Journal:  BMC Neurol       Date:  2012-12-05       Impact factor: 2.474

10.  Regional brain metabolism in a murine systemic lupus erythematosus model.

Authors:  An Vo; Bruce T Volpe; Chris C Tang; Wynne K Schiffer; Czeslawa Kowal; Patricio T Huerta; Aziz M Uluğ; Stephen L Dewey; David Eidelberg; Betty Diamond
Journal:  J Cereb Blood Flow Metab       Date:  2014-05-14       Impact factor: 6.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.